Mechanism of breast cancer metastasis suppressor gene 1 inhibiting tumor metastasis

doi:10.3760/cma.j.issn.1673-422X.2016.08.014

Abstract

Abstract: Breast cancer metastasis suppressor gene 1(BRMS1) significantly reduces the invasion and metastasis of cancer cells. BRMS1 gene expression is decreased or deleted in the cells of various malignant tumors. BRMS1 gene can inhibit tumor cells invasion and metastasis by means of regulating gene transcription and protein translation by phosphoinositide signaling and nuclear factor-κB (NF-κB) signaling pathways, repairing intercellular communication and interacting with the mSin3histone deacetylase (HDAC) complex, estrogen receptor and other proteins. BRMS1 gene may be a new target for the gene treatment of tumor metastasis.

Key words: Gene, neoplasm, Tumor metastasis, Breast cancer metastasis suppressor gene 1, Inhibiting effect

Mao Li, Cui Caiping, Zhang Jing, Zhou Ping. Mechanism of breast cancer metastasis suppressor gene 1 inhibiting tumor metastasis[J]. Journal of International Oncology, 2016, 43(8): 619-621.

References

［1］ Hedley BD, Vaidya KS, Phadke P, et al. BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation［J］. Clin Exp Metastasis, 2008, 25(7): 727-740. DOI： 10.1007/s10585-008-9184-0. ［2］ Wu Y, Mcewen GD, Harihar S, et al. BRMS1 expression alters the ultrastructural, biomechanical and biochemical properties of MDA-MB-435 human breast carcinoma cells: an AFM and Raman microspectroscopy study［J］. Cancer Lett, 2010, 293(1): 82-91. DOI： 10.1016/j.canlet.2009.12.016. ［3］ Wu Y, Jiang W, Wang Y, et al. Breast cancer metastasis suppressor 1 regulates hepatocellular carcinoma cell apoptosis via suppressing osteopontin expression［J］. PLoS One, 2012, 7(8): e42976. DOI： 10.1371/journal.pone.0042976. ［4］ You J, He X, Ding H, et al. BRMS1 regulates apoptosis in nonsmall cell lung cancer cells［J］. Cell Biochem Biophys, 2015, 71(1): 465-472. DOI： 10.1007/s12013-014-0226-8. ［5］ Vaidya KS, Harihar S, Phadke PA, et al. Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling［J］. J Biol Chem, 2008, 283(42): 28354-28360. DOI： 10.1074/jbc.M710068200. ［6］ Liu Y, Mayo MW, Xiao A, et al. Loss of BRMS1 promotes a mesenchymal phenotype through NF-κBdependent regulation of Twist1［J］. Mol Cell Biol, 2015, 35(1): 303-317. DOI： 10.1128/MCB.00869-14. ［7］ Mei P, Bai J, Shi M, et al. BRMS1 suppresses glioma progression by regulating invasion, migration and adhesion of glioma cells［J］. PLoS One, 2014, 9(5): e98544. DOI： 10.1371/journal.pone.0098544. ［8］ Xing WJ, Liao XH, Wang N, et al. MRTF-A and STAT3 promote MDA-MB-231 cell migration via hypermethylating BRSM1［J］. IUBMB Life, 2015, 67(3): 202-217. DOI： 10.1002/iub.1362. ［9］ Slipicevic A, Holm R, Emilsen E, et al. Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased diseasefree survival［J］. BMC Cancer, 2012, 12: 73. DOI： 10.1186/1471-2407-12-73. ［10］ Hurst DR. Metastasis suppression by BRMS1 associated with SIN3 chromatin remodeling complexes［J］. Cancer Metastasis Rev, 2012, 31(3/4): 641651. DOI: 10.1007/s10555-012-9363-y. ［11］ Gong C, Qu S, Lv XB, et al. BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10［J］. Nat Commun, 2014, 5: 5406. DOI： 10.1038/ncomms6406. ［12］ Roesley SN, Suryadinata R, Morrish E, et al. Cyclindependent kinasemediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration［J］. Cell Cycle, 2016, 15(1): 137-151. DOI： 10.1080/15384101.2015.1121328. ［13］ Edmonds MD, Hurst DR, Vaidya KS, et al. Breast cancer metastasis suppressor 1 coordinately regulates metastasisassociated microRNA expression［J］. Int J Cancer, 2009, 125(8): 1778-1785. DOI： 10.1002/ijc.24616. ［14］ Bodenstine TM, Vaidya KS, Ismail A, et al. Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition［J］. Cancer Res, 2010, 70(23): 10002-10011. DOI： 10.1158/0008-5472.CAN-10-2606. ［15］ Ma H, Gollahon LS. ERα mediates estrogeninduced expression of the breast cancer metastasis suppressor gene BRMS1［J］. Int J Mol Sci, 2016, 17(2): 10. DOI： 10.3390/ijms17020158. ［16］ Wu J, Wang Y, Qiao X, et al. Cloning and characterization of a novel human BRMS1 transcript variant in hepatocellular carcinoma cells［J］. Cancer Lett, 2013, 337(2): 266-275. DOI： 10.1016/j.canlet.2013.04.030. ［17］ Kramer D, Schn M, Bayerlová M, et al. A pro-apoptotic function of iASPP by stabilizing p300 and CBP through inhibition of BRMS1 E3 ubiquitin ligase activity［J］. Cell death disease, 2015, 6: e1634. DOI： 10.1038/cddis.2015.17. ［18］ Balgkouranidou I, Chimonidou M, Milaki G, et al. Breast cancer metastasis suppressor1 promoter methylation in cellfree DNA provides prognostic information in non-small cell lung cancer［J］. Br J Cancer, 2014, 110(8): 2054-2062. DOI： 10.1038/bjc.2014.104.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297.